ArticlePloS one2026

Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma.

Yanyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.